Lv22
170 积分 2024-09-16 加入
Inflammatory Cutaneous Lesions in Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab: An ECCO CONFER Multicentre Case Series
12小时前
求助中
Incidence and Risk Factors for Development of Acne (JAKne) in Patients with Inflammatory Bowel Disease Treated With Upadacitinib
1天前
已关闭
Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial
18天前
已完结
Systematic review with meta‐analysis: loss of response and requirement of ustekinumab dose escalation in inflammatory bowel diseases
8个月前
已完结
Pharmacogenomics and the Resulting Impact on Psoriasis Therapies
8个月前
已完结
A polymorphism in the gene encoding the Fc IIIA receptor is a possible genetic marker to predict the primary response to infliximab in Japanese patients with rheumatoid arthritis
8个月前
已完结
A novel PCR-based method for direct Fcγ receptor IIIa (CD16) allotyping
8个月前
已完结
Influence of variants of Fc receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor therapy in rheumatoid arthritis
8个月前
已完结
Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab
8个月前
已完结
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study
8个月前
已完结
皖公网安备34019202002308
